Eli Lilly & Co. Zepbound injection pens arranged in a tray. Photographer: Shelby Knowles/Bloomberg
© 2024 Bloomberg Finance LP
Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month—well below the…
Eli Lilly & Co. Zepbound injection pens arranged in a tray. Photographer: Shelby Knowles/Bloomberg
© 2024 Bloomberg Finance LP
Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month—well below the…